|
IRWD | Ironwood Pharmaceuticals Inc |
|
|
IRWD | Ironwood Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.52 |
| Leverage | 179.93% |
| Market Cap | $ 596.4m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -2.5m |
| Margin | -0.73% |
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.